Roger Royster to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Roger Royster has written about Adrenergic beta-Antagonists.
Connection Strength
0.329
-
Zvara DA, Brooker RF, McCall WV, Foreman AS, Hewitt C, Murphy BA, Royster RL. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy. Convuls Ther. 1997 Sep; 13(3):165-74.
Score: 0.153
-
MacGregor DA, Butterworth JF, Zaloga CP, Prielipp RC, James R, Royster RL. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest. 1994 Sep; 106(3):835-41.
Score: 0.124
-
Harwood TN, Butterworth J, Prielipp RC, Royster RL, Hansen K, Plonk G, Dean R. The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth. 1999 Oct; 13(5):555-61.
Score: 0.044
-
Ririe DG, Butterworth JF, Royster RL, MacGregor DA, Zaloga GP. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate. Anesthesiology. 1995 Apr; 82(4):1004-12.
Score: 0.008